WKN: | 120159 |
ISIN: | US64049M2098 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Neogenomics-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 15. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2019 | 10,58 | 26,40 | 149,53% |
2 | 2015 | 3,32 | 7,50 | 125,90% |
3 | 2023 | 8,73 | 15,30 | 75,26% |
4 | 2020 | 26,40 | 42,80 | 62,12% |
5 | 2018 | 7,53 | 10,58 | 40,50% |
6 | 2016 | 7,50 | 8,22 | 9,60% |
7 | 2024 | 15,30 | 15,90 | 3,92% |
8 | 2017 | 8,22 | 7,53 | -8,39% |
9 | 2021 | 42,80 | 28,86 | -32,57% |
10 | 2025 | 15,90 | 7,05 | -55,66% |
11 | 2022 | 28,86 | 8,73 | -69,75% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2022 | 28,86 | 8,73 | -69,75% |
2 | 2025 | 15,90 | 7,05 | -55,66% |
3 | 2021 | 42,80 | 28,86 | -32,57% |
4 | 2017 | 8,22 | 7,53 | -8,39% |
5 | 2024 | 15,30 | 15,90 | 3,92% |
6 | 2016 | 7,50 | 8,22 | 9,60% |
7 | 2018 | 7,53 | 10,58 | 40,50% |
8 | 2020 | 26,40 | 42,80 | 62,12% |
9 | 2023 | 8,73 | 15,30 | 75,26% |
10 | 2015 | 3,32 | 7,50 | 125,90% |
11 | 2019 | 10,58 | 26,40 | 149,53% |